Literature DB >> 355066

Plasma lipids and lipoproteins in liver disease.

N McIntyre.   

Abstract

There are many changes in the plasma, lipids, and lipoproteins in patients with liver disease. They have proved difficult to study but our understanding of these changes has increased greatly during recent years. In obstructive jaundice hyperlipidaemia is a fairly constant finding and this appears to be due to the regurgitation of phospholipid from the obstructed biliary tree. The plasma lipids tend to fall with parenchymal liver disease. The composition of the lipoproteins depends on the activity of the plasma enzyme lecithin: cholesterol acyl transferase. When LCAT activity is high the individual lipoprotein fractions are normal. When it is reduced all of the lipoprotein fractions are affected but the pattern found with obstruction is quite different from that found with parenchymal disease. The changes in plasma lipoproteins appear to be associated with change in the lipid composition of cellular membranes and this may have important functional implications.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 355066      PMCID: PMC1412050          DOI: 10.1136/gut.19.6.526

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  22 in total

1.  The lipid composition of serum in patients with liver disease.

Authors:  G B PHILLIPS
Journal:  J Clin Invest       Date:  1960-11       Impact factor: 14.808

2.  Protein-lipid relationships in human plasma: in biliary cirrhosis, obstructive jaundice, and acute hepatitis.

Authors:  H A EDER; E M RUSS; R A R PRITCHETT; M M WILBER; D P BARR
Journal:  J Clin Invest       Date:  1955-07       Impact factor: 14.808

3.  Ultracentrifugal characterization of the lipoprotein spectrum in obstructive jaundice: studies of serum lipid relationships in intra-and extrahepatic biliary obstruction.

Authors:  R H FURMAN; L L CONRAD
Journal:  J Clin Invest       Date:  1957-05       Impact factor: 14.808

4.  Lipoproteins in primary biliary cirrhosis.

Authors:  E M RUSS; J RAYMUNT; D P BARR
Journal:  J Clin Invest       Date:  1956-02       Impact factor: 14.808

5.  Lipoproteins in infectious and serum hepatitis.

Authors:  F T PIERCE; J R KIMMEL; T W BURNS
Journal:  Metabolism       Date:  1954-05       Impact factor: 8.694

6.  THE LIPIDS OF SERUM AND LIVER IN PATIENTS WITH HEPATIC DISEASES.

Authors:  E B Man; B L Kartin; S H Durlacher; J P Peters
Journal:  J Clin Invest       Date:  1945-09       Impact factor: 14.808

7.  Lipoproteins, liver disease, and atherosclerosis.

Authors:  F T PIERCE; J W GOFMAN
Journal:  Circulation       Date:  1951-07       Impact factor: 29.690

8.  Serum lipids in infectious hepatitis and obstructive jaundice.

Authors:  M J ALBRINK; E B MAN; J P PETERS
Journal:  J Clin Invest       Date:  1950-06       Impact factor: 14.808

9.  The ultrastructure of plasma lipoproteins in lecithin:cholesterol acyltransferase deficiency.

Authors:  T Forte; A Nichols; J Glomset; K Norum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1974

10.  A lipoprotein characterizing obstructive jaundice. II. Isolation and partial characterization of the protein moieties of low density lipoproteins.

Authors:  D Seidel; P Alaupovic; R H Furman; W J McConathy
Journal:  J Clin Invest       Date:  1970-12       Impact factor: 14.808

View more
  20 in total

Review 1.  Plasma lipoproteins, lipid transport, and atherosclerosis: recent developments.

Authors:  N E Miller
Journal:  J Clin Pathol       Date:  1979-07       Impact factor: 3.411

Review 2.  Abnormalities of Lipoprotein Levels in Liver Cirrhosis: Clinical Relevance.

Authors:  Graziella Privitera; Luisa Spadaro; Simona Marchisello; Giuseppe Fede; Francesco Purrello
Journal:  Dig Dis Sci       Date:  2017-11-25       Impact factor: 3.199

3.  Effect of Sargassum polycystum (Phaeophyceae)-sulphated polysaccharide extract against acetaminophen-induced hyperlipidemia during toxic hepatitis in experimental rats.

Authors:  Hanumantha Rao Balaji Raghavendran; Arumugam Sathivel; Thiruvengadam Devaki
Journal:  Mol Cell Biochem       Date:  2005-08       Impact factor: 3.396

4.  Liver disease alters high-density lipoprotein composition, metabolism and function.

Authors:  Markus Trieb; Angela Horvath; Ruth Birner-Gruenberger; Walter Spindelboeck; Vanessa Stadlbauer; Ulrike Taschler; Sanja Curcic; Rudolf E Stauber; Michael Holzer; Lisa Pasterk; Akos Heinemann; Gunther Marsche
Journal:  Biochim Biophys Acta       Date:  2016-04-19

5.  Sterol and bile acid metabolism after short-term prednisolone treatment in patients with chronic active hepatitis.

Authors:  Y Yamanishi; Y Nosaka; H Kawasaki; C Hirayama; S Ikawa
Journal:  Gastroenterol Jpn       Date:  1985-06

6.  Changes in high density lipoproteins in patients with hepatobiliary diseases. Levels and lipid composition of HDL2 and HDL3 and LCAT reaction.

Authors:  G Kajiyama; K Takata; I Horiuchi; M Nakagawa; M Yamamoto; A Miyoshi
Journal:  Gastroenterol Jpn       Date:  1983-04

7.  Lipoproteins, HDL-apolipoproteins, activities of hepatic lipase and lecithin-cholesterol acyltransferase in the plasma of patients with post-alcoholic end-stage liver cirrhosis.

Authors:  C Breier; H J Lisch; H Braunsteiner
Journal:  Klin Wochenschr       Date:  1983-09-15

8.  High-density lipoprotein response to alcohol consumption and abstinence as an indicator of liver function in alcoholic patients.

Authors:  P Devenyi; B M Kapur; J H Roy
Journal:  Can Med Assoc J       Date:  1984-06-01       Impact factor: 8.262

Review 9.  Alcohol and high-density lipoproteins.

Authors:  P Devenyi; G M Robinson; D A Roncari
Journal:  Can Med Assoc J       Date:  1980-11-22       Impact factor: 8.262

10.  Serum lipid profile in alcoholic cirrhosis: A study in a teaching hospital of north-eastern India.

Authors:  Jyoti Prakash Phukan; Anuradha Sinha; Jatindra Prasad Deka
Journal:  Niger Med J       Date:  2013-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.